Abstract
AbstractA rift that has opened up between basic research (bench) and clinical research and patients (bed) who need their new treatments, diagnostics and prevention, and this rift is widening and getting deeper. The crisis involving the “translation” of basic scientific findings in a laboratory setting into human applications and potential treatments or biomarkers for a disease is widely recognized both in academia and industry. Despite the attempts that have been made both in academic and industry settings to mitigate this problem, the high attrition rates of drug development and the problem with reproducibility and translatability of preclinical findings to human applications remain a fact and the return on the investment has been limited in terms of clinical impact.Here I provide an overview of the challenges facing the drug development, and translational discordance with specific focus on a number of “culprits” in translational research including poor hypothesis, irreproducible data, ambiguous preclinical models, statistical errors, the influence of organizational structures, lack of incentives in the academic setting, governmental funding mechanisms, the clinical relevance of basic research, insufficient transparency, and lack of data sharing in research. I further provide some suggestions and new strategies that include some new aspects on open innovation models, entrepreneurship, transparency, and decision making to overcome each of the many problems during the drug discovery and development process and to more dynamically adjust for innovation challenges with broader scientific feedback.
Publisher
Springer Science and Business Media LLC
Reference132 articles.
1. Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A. Translational medicine definition by the European Society for Translational Medicine. Eur J Mol Clin Med. 2014;2:86.
2. Lum C, Koper CS. Evidence-based policing: translating research into practice. USA: Oxford University Press; 2017.
3. Carini C, Seyhan AA, Fidock MD, van Gool AJ. Definitions and conceptual framework of Biomarkers in Precision Medicine. Handbook of Biomarkers and Precision Medicine. In: Claudio Carini MF, van Gool A, editors. Handbook of Biomarkers and Precision Medicine. New York: Chapman and Hall/CRC; 2019. p. 2.
4. Woolf SH. The meaning of translational research and why it matters. JAMA. 2008;299:211–3.
5. Fontanarosa PB, DeAngelis CD. Basic science and translational research in JAMA. JAMA. 2002;287:1728.
Cited by
381 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献